Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Selumetinib bulk supplier for pharma manufacturers

Selumetinib 10mg, 25mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 10mg, 25mg

Reference Brands: Koselugo (USA)

Category: Neurology

Selumetinib is a selective inhibitor of the enzymes MEK1 and MEK2, which are part of a signalling pathway involved in cell growth and division. By blocking MEK1/2, selumetinib helps reduce abnormal growth of nerve-sheath tumors (plexiform neurofibromas) in people with genetic disorder Neurofibromatosis type 1 (NF1). Koselugo is indicated for patients (children and now adults) with symptomatic, inoperable plexiform neurofibromas — helping shrink tumor volume or slow growth when surgical removal is not feasible.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Selumetinib — third party manufacturing & bulk supply

Selumetinib 10mg, 25mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Selumetinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Selumetinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Selumetinib →
Back to Listing

Frequently Asked Questions

Selumetinib is used to treat neurofibromatosis type 1 (NF1) in children with inoperable plexiform neurofibromas. It works by inhibiting the MEK1 and MEK2 enzymes in the RAS/MAPK pathway, which helps reduce tumor growth.

Selumetinib is made from the active pharmaceutical ingredient selumetinib hydrochloride, a small-molecule MEK inhibitor.

The trade name is Koselugo.

Koselugo is manufactured by AstraZeneca.

The generic name is selumetinib hydrochloride.

The primary brand name is Koselugo.

It is manufactured in approved pharmaceutical facilities in Europe and the USA, depending on regulatory approvals.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.